Pre-Clinical Research RFA Description

This RFA supports pre-clinical (non-human)) research of new or repurposed drugs and biologics in the areas of neuroprotection, regeneration and plasticity, at the pre-IND or pre-IDE development stage. This RFA does not encompass full drug screens, IND/IDE enabling studies or clinical as the costs are beyond the scope of this RFA.

Suggested areas of focus (applicable areas for drugs, biologics and devices are within the scope of this RFA):


Phenotypic drug development/targets will be considered if a mechanistic rationale is provided.

Eligibility and Requirements

Funding/Budget

The total budget includes direct and indirect costs.  Indirect costs are limited to 10% of the total budget.

Data Sharing and Publication

Additional Requirements

How your money helps

With your generosity we are able to fund groundbreaking research with the power to transform lives.

Read more

Spinal Research and Reeve Foundation announce joint international research call.

Read more

Donate

Your generous donation today will make a real difference, helping us drive forward vital research.

Read more